BioSpace News Archive

Business

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

TELA Bio, Inc. today announced that the Company will report second quarter 2023 financial results on Wednesday, August 9, 2023.

July 26, 2023
·
2 min read
Business

Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update

Editas Medicine, Inc. today announced that it will host a conference call and webcast on Wednesday, August 2, 2023, at 8:00 a.m. ET to discuss results for the second quarter 2023 and to provide a corporate update.

July 26, 2023
·
1 min read
Lone Star Bio

Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023

Marker Therapeutics, Inc. today announced participation in a live webcast produced by Demy-Colton and sponsored by the WBB Research Institute titled “Beyond CAR-T, What’s Next for Cell Therapy”.

July 26, 2023
·
5 min read
Business

Karyopharm to Report Second Quarter 2023 Financial Results on August 2, 2023

Karyopharm Therapeutics Inc. today announced it will report second quarter 2023 financial results on Wednesday, August 2, 2023.

July 26, 2023
·
2 min read
Biotech Bay

Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption

Veeva Systems revealed findings of field medical’s impact on clinical practice in the Veeva Pulse Field Trends Report.

July 26, 2023
·
4 min read
Bio NC

Verona Pharma to Present at 43rd Annual Canaccord Growth Conference

Verona Pharma plc announces that senior management will present a company overview at the 43rd Annual Canaccord Growth Conference on Wednesday, August 9, 2023 at 12:00 PM EDT / 5:00 PM BST.

July 26, 2023
·
2 min read
Business

Children’s Hospital Colorado Launches State’s First Pediatric Precision Medicine Institute

Children’s Hospital Colorado announced the launch of the Precision Medicine Institute, which will allow experts to more efficiently integrate precision medicine into care provided to patients throughout the hospital.

July 26, 2023
·
5 min read
Business

REGENXBIO to Host Conference Call on August 2 to Discuss Second Quarter 2023 Financial Results and Recent Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, August 2, 2023 , at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2023 , and recent operational highlights.

July 26, 2023
·
1 min read
IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process

IMV Inc. (the “ Company ” or “ IMV ”), recently announced an update on the Sales and Investment Solicitation Process (the “ SISP ”) implemented as part of its ongoing proceedings under the Companies’ Creditors Arrangement Act (the “ CCAA ”).

July 26, 2023
·
6 min read
Business

Nephros Schedules Second Quarter 2023 Financial Results Conference Call

Nephros, Inc. today announced that it will file its second-quarter financial results on Wednesday, August 9, 2023 after market close and will host a conference call that same day at 4:30pm ET.

July 26, 2023
·
1 min read